Report
Jake Strole
EUR 100.00 For Business Accounts Only

Growth Headwinds Continue, but Cantel's Narrow Moat Remains Intact; Maintain $92 Fair Value Estimate

Cantel Medical posted fiscal first-quarter results that fell modestly short of our expectations on a reported basis but largely in line with our organic revenue forecast. Cash flow, however, remains on track to meet our expectations for the firm's fiscal year, and we'll likely maintain our $92 per share fair value estimate as a result. While 2019 remains a year of transition and investment for the organization, we think our implied valuation multiple of 35 times adjusted earnings is supported by...
Underlying
Cantel Medical Corp.

Cantel Medical is a provider of infection prevention products and services in the healthcare market. The company has four segments: Medical, which designs, develops, manufactures, sells and installs products and services comprising a circle of infection prevention solutions; Life Sciences, which designs, develops, manufactures, sells, and installs water purification systems; Dental, which designs, manufactures, sells, supplies and distributes infection prevention healthcare products; and Dialysis, which designs, develops, manufactures, sells and services reprocessing systems and sterilants for dialyzers, as well as dialysate concentrates and supplies utilized for renal dialysis

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jake Strole

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch